Cargando…
Naotaifang III Protects Against Cerebral Ischemia Injury Through LPS/TLR4 Signaling Pathway in the Microbiota–Gut–Brain Axis
BACKGROUND: Ischemic stroke (IS) is a leading cause of mortality worldwide. Naotaifang III is a new Chinese herbal formula to treat IS. Previous studies have shown that Astragali Radix, Puerariae Lobatae Radix, Chuanxiong Rhizoma, and Rhei Radix Et Rhizoma in Naotaifang III were able to regulate the...
Autores principales: | Nie, Huifang, Ge, Jinwen, Yang, Kailin, Peng, Zhuli, Wu, Haihui, Yang, Tong, Mei, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697094/ http://dx.doi.org/10.2147/DDDT.S421658 |
Ejemplares similares
-
Metabonomics Study on Naotaifang Extract Alleviating Neuronal Apoptosis after Cerebral Ischemia-Reperfusion Injury
por: Xu, Dehong, et al.
Publicado: (2022) -
An Integrated Analysis of Network Pharmacology and Experimental Validation to Reveal the Mechanism of Chinese Medicine Formula Naotaifang in Treating Cerebral Ischemia-Reperfusion Injury
por: Yang, Tong, et al.
Publicado: (2021) -
Naotaifang extract treatment results in increased ferroportin expression in the hippocampus of rats subjected to cerebral ischemia
por: LIAO, JUN, et al.
Publicado: (2015) -
Naotaifang extract treatment results in increased ferroportin expression in the hippocampus of rats subjected to cerebral ischemia
por: Liao, Jun, et al.
Publicado: (2016) -
Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial
por: Fang, Rui, et al.
Publicado: (2023)